ZA200610664B - Process for formulating fast dispersing dosage forms comprising at least one fish gelatin selected on the basis of molecular weight - Google Patents
Process for formulating fast dispersing dosage forms comprising at least one fish gelatin selected on the basis of molecular weight Download PDFInfo
- Publication number
- ZA200610664B ZA200610664B ZA200610664A ZA200610664A ZA200610664B ZA 200610664 B ZA200610664 B ZA 200610664B ZA 200610664 A ZA200610664 A ZA 200610664A ZA 200610664 A ZA200610664 A ZA 200610664A ZA 200610664 B ZA200610664 B ZA 200610664B
- Authority
- ZA
- South Africa
- Prior art keywords
- molecular weight
- gelatin
- process according
- oral
- dosage form
- Prior art date
Links
- 108010010803 Gelatin Proteins 0.000 title claims description 107
- 229920000159 gelatin Polymers 0.000 title claims description 107
- 235000019322 gelatine Nutrition 0.000 title claims description 107
- 235000011852 gelatine desserts Nutrition 0.000 title claims description 107
- 239000008273 gelatin Substances 0.000 title claims description 101
- 238000000034 method Methods 0.000 title claims description 53
- 239000002552 dosage form Substances 0.000 title claims description 47
- 241000251468 Actinopterygii Species 0.000 title claims description 44
- 239000000203 mixture Substances 0.000 claims description 25
- 239000007787 solid Substances 0.000 claims description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 23
- 239000004480 active ingredient Substances 0.000 claims description 21
- 239000002904 solvent Substances 0.000 claims description 20
- 239000013543 active substance Substances 0.000 claims description 17
- 239000003814 drug Substances 0.000 claims description 13
- 238000009826 distribution Methods 0.000 claims description 10
- 238000009472 formulation Methods 0.000 claims description 10
- 239000012530 fluid Substances 0.000 claims description 7
- 238000004108 freeze drying Methods 0.000 claims description 7
- 210000000214 mouth Anatomy 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 239000008194 pharmaceutical composition Substances 0.000 claims description 4
- 238000007605 air drying Methods 0.000 claims description 3
- 239000003086 colorant Substances 0.000 claims description 2
- 239000013020 final formulation Substances 0.000 claims description 2
- 239000000796 flavoring agent Substances 0.000 claims description 2
- 235000013355 food flavoring agent Nutrition 0.000 claims description 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 2
- 229940124597 therapeutic agent Drugs 0.000 claims description 2
- 238000010521 absorption reaction Methods 0.000 description 8
- 239000006185 dispersion Substances 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 239000007788 liquid Substances 0.000 description 5
- 239000006186 oral dosage form Substances 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 239000002775 capsule Substances 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 238000004806 packaging method and process Methods 0.000 description 3
- 239000006187 pill Substances 0.000 description 3
- 239000007909 solid dosage form Substances 0.000 description 3
- 238000000859 sublimation Methods 0.000 description 3
- 230000008022 sublimation Effects 0.000 description 3
- 230000000153 supplemental effect Effects 0.000 description 3
- 230000009747 swallowing Effects 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 239000012876 carrier material Substances 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000027089 Parkinsonian disease Diseases 0.000 description 1
- 206010034010 Parkinsonism Diseases 0.000 description 1
- 235000017276 Salvia Nutrition 0.000 description 1
- 240000007164 Salvia officinalis Species 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000005178 buccal mucosa Anatomy 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000011067 equilibration Methods 0.000 description 1
- 238000010579 first pass effect Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- -1 for example Substances 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000006208 topical dosage form Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2063—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Emergency Medicine (AREA)
- Botany (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/860,106 US7972621B2 (en) | 2004-06-03 | 2004-06-03 | Process for formulating fast dispersing dosage forms comprising at least one fish gelatin selected on the basis of molecular weight |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200610664B true ZA200610664B (en) | 2007-12-27 |
Family
ID=35449231
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200610664A ZA200610664B (en) | 2004-06-03 | 2006-12-18 | Process for formulating fast dispersing dosage forms comprising at least one fish gelatin selected on the basis of molecular weight |
Country Status (19)
Country | Link |
---|---|
US (1) | US7972621B2 (zh) |
EP (1) | EP1765299B1 (zh) |
JP (1) | JP5144258B2 (zh) |
KR (1) | KR101161430B1 (zh) |
CN (2) | CN102172345B (zh) |
AU (1) | AU2005251773B2 (zh) |
BR (1) | BRPI0511067B8 (zh) |
CA (1) | CA2567830C (zh) |
DK (1) | DK1765299T3 (zh) |
ES (1) | ES2654293T3 (zh) |
HU (1) | HU230429B1 (zh) |
IL (1) | IL179777A (zh) |
IS (1) | IS8588A (zh) |
MX (1) | MXPA06013921A (zh) |
NO (1) | NO342135B1 (zh) |
PL (2) | PL218958B1 (zh) |
RU (1) | RU2415665C2 (zh) |
WO (1) | WO2005120464A1 (zh) |
ZA (1) | ZA200610664B (zh) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9908014D0 (en) * | 1999-04-08 | 1999-06-02 | Scherer Corp R P | Pharmaceutical compositions |
US20060210590A1 (en) | 2005-02-03 | 2006-09-21 | Alk-Abello A/S | Minor allergen control to increase safety of immunotherapy |
CA2608716A1 (en) | 2005-05-19 | 2006-11-23 | Kilda Biolink As | Gelatin-containing topical composition |
DE102006033168A1 (de) * | 2006-07-10 | 2008-01-17 | Gelita Ag | Verwendung von Gelatine und einem Vernetzungsmittel zur Herstellung einer vernetzenden therapeutischen Zusammensetzung |
JP5547096B2 (ja) * | 2008-02-28 | 2014-07-09 | アール.ピー. シェーラー テクノロジーズ エルエルシー | 多型を最小化する方法 |
US10548839B2 (en) | 2010-03-16 | 2020-02-04 | Wei Tian | Process of manufacturing a lyophilized fast dissolving, multi-phasic dosage form |
US9956169B2 (en) * | 2010-10-08 | 2018-05-01 | R.P. Scherer Technologies, Llc | Oral vaccine fast-dissolving dosage form using starch |
EP4371554A2 (en) | 2016-12-31 | 2024-05-22 | BioXcel Therapeutics, Inc. | Use of sublingual dexmedetomidine for the treatment of agitation |
CN114983980A (zh) | 2018-06-27 | 2022-09-02 | 比奥克斯塞尔医疗股份有限公司 | 含右美托咪定的膜制剂及其制造方法 |
US11523988B2 (en) | 2018-11-29 | 2022-12-13 | Catalent U.K. Swindon Zydis Limited | Oral dispersible vaccine comprising virosomes |
BR112022000992A2 (pt) | 2019-07-19 | 2022-06-14 | Arx Llc | Regimes de tratamento de dexmedetomidina não sedantes |
US11672761B2 (en) | 2020-11-16 | 2023-06-13 | Orcosa Inc. | Rapidly infusing platform and compositions for therapeutic treatment in humans |
CN117529324A (zh) | 2021-06-11 | 2024-02-06 | 奥夫艾治疗公司 | 稳定的阿匹莫德组合物和其用途 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1548022A (en) | 1976-10-06 | 1979-07-04 | Wyeth John & Brother Ltd | Pharmaceutial dosage forms |
GB2111423B (en) | 1981-12-02 | 1985-06-26 | Wyeth John & Brother Ltd | Making quick-dissolving pills |
US4760094A (en) | 1986-10-21 | 1988-07-26 | American Home Products Corporation (Del.) | Spray dried acetaminophen |
US4767789A (en) | 1986-10-21 | 1988-08-30 | American Home Products Corporation (Del.) | Spray dried acetaminophen |
US4760093A (en) | 1986-10-21 | 1988-07-26 | American Home Products Corporation (Del.) | Spray dried acetaminophen |
US5079018A (en) | 1989-08-14 | 1992-01-07 | Neophore Technologies, Inc. | Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs |
US5039540A (en) | 1989-08-14 | 1991-08-13 | Neophore Technologies, Inc. | Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs |
US5215756A (en) | 1989-12-22 | 1993-06-01 | Gole Dilip J | Preparation of pharmaceutical and other matrix systems by solid-state dissolution |
US5298261A (en) | 1992-04-20 | 1994-03-29 | Oregon Freeze Dry, Inc. | Rapidly distintegrating tablet |
CA2127702C (en) | 1992-11-11 | 2000-11-07 | Nobuyuki Kagami | Polyester composition and film made therefrom |
US6726928B2 (en) | 1994-10-28 | 2004-04-27 | R.P. Scherer Technologies, Inc. | Process for preparing solid dosage forms for unpalatable pharmaceuticals |
AU2190697A (en) | 1996-04-12 | 1997-11-07 | Flemington Pharmaceutical Corporation | Buccal polar spray or capsule |
US6258380B1 (en) | 1999-03-05 | 2001-07-10 | Banner Pharmacaps, Inc. | Chewable soft capsule |
GB9908014D0 (en) * | 1999-04-08 | 1999-06-02 | Scherer Corp R P | Pharmaceutical compositions |
US6284270B1 (en) | 1999-08-04 | 2001-09-04 | Drugtech Corporation | Means for creating a mass having structural integrity |
US6709699B2 (en) * | 2000-09-27 | 2004-03-23 | Kabushiki Kaisha Toshiba | Film-forming method, film-forming apparatus and liquid film drying apparatus |
US6706669B2 (en) * | 2001-07-13 | 2004-03-16 | Exxonmobil Research And Engineering Company | Method for inhibiting corrosion using phosphorous acid |
GB0210397D0 (en) * | 2002-05-07 | 2002-06-12 | Ferring Bv | Pharmaceutical formulations |
DE60307082D1 (de) * | 2002-05-07 | 2006-09-07 | Ferring Bv | In der mundhöhle dispergierbare phamarzeutische zusammensetzung mit desmopressin |
GB2388776B (en) * | 2002-05-21 | 2004-08-25 | Croda Int Plc | Succinylated fish gelatin for use as a blood plasma expander |
GB0226076D0 (en) | 2002-11-08 | 2002-12-18 | Rp Scherer Technologies Inc | Improved formulations containing substituted imidazole derivatives |
-
2004
- 2004-06-03 US US10/860,106 patent/US7972621B2/en active Active
-
2005
- 2005-06-03 RU RU2006147244/15A patent/RU2415665C2/ru active
- 2005-06-03 WO PCT/US2005/019589 patent/WO2005120464A1/en active Application Filing
- 2005-06-03 JP JP2007515624A patent/JP5144258B2/ja active Active
- 2005-06-03 BR BRPI0511067A patent/BRPI0511067B8/pt active IP Right Grant
- 2005-06-03 PL PL382307A patent/PL218958B1/pl unknown
- 2005-06-03 AU AU2005251773A patent/AU2005251773B2/en active Active
- 2005-06-03 ES ES05758824.6T patent/ES2654293T3/es active Active
- 2005-06-03 CN CN201110058244.1A patent/CN102172345B/zh active Active
- 2005-06-03 KR KR1020077000078A patent/KR101161430B1/ko active IP Right Grant
- 2005-06-03 MX MXPA06013921A patent/MXPA06013921A/es active IP Right Grant
- 2005-06-03 CN CNA2005800178323A patent/CN1960710A/zh active Pending
- 2005-06-03 PL PL05758824T patent/PL1765299T3/pl unknown
- 2005-06-03 DK DK05758824.6T patent/DK1765299T3/en active
- 2005-06-03 CA CA2567830A patent/CA2567830C/en active Active
- 2005-06-03 HU HU0700043A patent/HU230429B1/hu unknown
- 2005-06-03 EP EP05758824.6A patent/EP1765299B1/en active Active
-
2006
- 2006-11-30 IL IL179777A patent/IL179777A/en active IP Right Grant
- 2006-12-18 ZA ZA200610664A patent/ZA200610664B/en unknown
- 2006-12-28 IS IS8588A patent/IS8588A/is unknown
- 2006-12-29 NO NO20066070A patent/NO342135B1/no unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200610664B (en) | Process for formulating fast dispersing dosage forms comprising at least one fish gelatin selected on the basis of molecular weight | |
RU2109509C1 (ru) | Композиция для буккального введения лекарственного средства и способ ее получения | |
ES2402544T3 (es) | Preparación pelicular rápidamente soluble | |
JP4943581B2 (ja) | 迅速分散性固形経口投与用剤形の製造方法 | |
Joshua et al. | Fast dissolving oral thin films: An effective dosage form for quick releases | |
HU227532B1 (en) | Pharmaceutical and other dosage forms and their preparation | |
Bhattarai et al. | Fast dissolving oral films: a novel trend to oral drug delivery system | |
CN109803647A (zh) | α-丁酮酸、α-酮戊二酸和2-羟基丁酸用于刺激毛发生长 | |
JP4790629B2 (ja) | 非ゼラチン化デンプンを含む咀嚼可能な軟カプセル | |
Gopale et al. | Medicated Lozenges: A Review: Artificial intelligence in drug discovery | |
Chandrawanshi Mayuri et al. | A review on medicated lozenges | |
JP4364869B2 (ja) | 咀嚼性カプセルの製造方法 | |
CN113440499B (zh) | 叶酸口溶膜剂及其制备方法 | |
AU2012241189A1 (en) | Fast Dissolving Solid Dosage Form | |
Mehta et al. | Fast Dissolving Films: Brief review on preparation methods, ingredients and technology used | |
Mostafa | Wafer technology as a novel drug delivery system | |
Bhirud et al. | Role of freeze drying technology in the development of orally disintegrating films | |
Patange et al. | A REVIEW ON MOUTH DISSOLVING FILMS | |
Gupta et al. | Review on Sublingual Tablets: A Promising Formulation for Instant Action | |
Anitha et al. | Pharmaceutical Oral Jellies-An Overview | |
WO2009055923A1 (en) | Ingestible film composition | |
Afreen et al. | A review on oral disintegrating tablets and oral soluble films | |
Srivastava et al. | Fast dissolving oral strips: Trends and applications | |
JPH10130140A (ja) | グミ製剤の製造方法 | |
WO1998002140A1 (fr) | Composition pharmaceutique destinee a une administration par voie buccale |